Viking Therapeutics

YTD

ALL

Trade Viking Therapeutics 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About VKTX

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A.

CEO

Brian Lian

CEOBrian Lian

Employees

Employees53

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

2012

Founded2012

Employees

Employees53

VKTX Key Statistics

Market cap

4.15B

Market cap4.15B

Price-Earnings ratio

-7.63

Price-Earnings ratio-7.63

Dividend yield

—

Dividend yield—

Average volume

11.68M

Average volume11.68M

High today

$39.05

High today$39.05

Low today

$35.10

Low today$35.10

Open price

$37.74

Open price$37.74

Volume

13.58M

Volume13.58M

52 Week high

$43.15

52 Week high$43.15

52 Week low

$24.88

52 Week low$24.88

Stock Snapshot

As of today, Viking Therapeutics(VKTX) shares are valued at $35.53. The company's market cap stands at 4.15B, with a P/E ratio of -7.63.

On 2026-09-27, Viking Therapeutics(VKTX) stock moved within a range of $35.10 to $39.05. With shares now at $35.53, the stock is trading +1.2% above its intraday low and -9.0% below the session's peak.

Trading volume for Viking Therapeutics(VKTX) stock has reached 13.58M, versus its average volume of 11.68M.

Over the past 52 weeks, Viking Therapeutics(VKTX) stock has traded between a high of $43.15 and a low of $24.88.

VKTX News

Simply Wall St 2d

What Viking Therapeutics Stock Means For Shareholders After Obesity Drug Data And $500 Million Raise - simplywall.st

...

TipRanks 3d

Viking Therapeutics Advances VK2735 Obesity Trial, Keeping VKTX in the Weight Loss Race

Viking Therapeutics (VKTX) announced an update on their ongoing clinical study. Viking Therapeutics, Inc. is running a Phase 1 trial called “A Phase 1 Study of...

Benzinga 4d

Viking Therapeutics Stock Drops In After Hours on Proposed Public Offerings

Viking Therapeutics Inc (NASDAQ:VKTX) shares are moving lower in extended trading Wednesday after the company announced a pair of proposed public offerings. Vi...

Analyst ratings

90%

of 20 ratings

Buy

90%

Hold

10%

Sell

More VKTX News

TipRanks 4d

Viking Therapeutics announces common stock, convertible senior notes offerings

Viking Therapeutics (VKTX) announced its intention to offer, subject to market and other conditions, $200M of common stock and $200M aggregate principal amount...

Benzinga 5d

Jaguar Health, IONQ, Viking Therapeutics, Xanadu Quantum and Grab Holdings: Why These 5 Stocks Are on Investors' Radars Today

Major U.S. indices closed mixed on Tuesday, with the Dow Jones Industrial Average falling 0.36% to 51,863.69, the S&P 500 ending virtually unchanged at 7,764.64...

People also own

Based on the portfolios of people who own VKTX. This list is generated using Robinhood data, and it’s not a recommendation.

Novo Nordisk

Plug Power

Corbus Pharmaceuticals

Tilray Brands

Pfizer

Moderna

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.